【Rich track record and stable supply】Human primary hepatocytes
Preci Inc. is a global vendor that provides high-quality and affordable human primary hepatocytes consistently. They have a track record of supplying approximately 8,000 vials of human primary hepatocytes annually, primarily to major pharmaceutical companies and CROs. Preci's human primary hepatocytes are suitable for various applications, including adherent culture, suspension culture, and spheroid culture. Particularly in products derived from multiple donors, they minimize variability in quality between batches, ensuring assay stability and reproducibility. Additionally, they provide not only frozen cells but also the media necessary for thawing and seeding.
Inquire About This Product
basic information
PR-LIV-P - Survival rate ≧ 80% - Cell count ≧ 7×10^6 cells/vial - Monolayer formation within 24 hours - Capable of monolayer culture for over 120 hours PR-LIV-S20 - Survival rate ≧ 80% - Cell count ≧ 5×10^6 cells/vial - Survival rate ≧ 75% after 6 hours - 10 women, 10 men PR-LIV-SPH - Survival rate ≧ 80% - Cell count ≧ 1×10^6 cells/vial - Spheroid formation after 7 to 10 days of culture - Capable of culture for 28 days
Price range
P3
Delivery Time
P3
Applications/Examples of results
Drug-drug interactions Hepatotoxicity test Hepatitis virus test Liver metabolism clearance test
catalog（1）
Download All Catalogs
Company information
Reprocell Inc. is a company that develops its business primarily in the fields of iPS cell and clinical testing. Even before the invention of iPS cells, we had been accumulating research on ES cells, and by leveraging that technology and extensive experience in iPS cells, we have successfully commercialized world-leading iPS cell products. We also provide research reagents, culture materials, clinical testing services such as cell and biological samples, drug discovery support services, and HLA typing. Please feel free to contact us when you need our services.